In this video, Paul B. Rosenberg, MD, discusses his team’s research on using dronabinol, a legal form of synthetic THC, to treat agitation in patients with Alzheimer disease. The study found that dronabinol...
In this video, Kasia Rothenberg, MD, PhD, describes Alzheimer disease-related agitation, details the difficulty in testing for Alzheimer disease-related agitation, looks ahead to potential treatment options...
In this video, Craig Chepke, MD, DFAPA, and Kevin Williams, MS, MPAS, PA-C provide the take-home messages from their session “Agitation in Alzheimer’s Dementia: Progress for an Age-Old Problem” at our...
In a small clinical trial, researchers found that patients taking suvorexant, an FDA-approved treatment for insomnia, had reduced levels of amyloid beta (amyloid-β) and tau phosphorylation proteins, which...
In this video, Craig Chepke, MD, DFAPA, and Kevin Williams, MS, MPAS, PA-C provide a preview of their session, "Agitation in Alzheimer’s Dementia: Progress for an Age-Old Problem ” at our Practical Updates...
In this video, Craig Chepke, MD, DFAPA, and Kevin Williams, MS, MPAS, PA-C Provide the take-home messages from their session “Agitation in Alzheimer’s Dementia: Progress for an Age-Old Problem” at our...
